Legislative Research: US HB8900 | 2019-2020 | 116th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2021-2022 117th Congress (Introduced - Dead) | To amend the National Defense Authorization Act for Fiscal Year 2021, to authorize certain prizes for the development of non-PFAS-containing turnout gear, and for other purposes. [HB8900 2021 Detail][HB8900 2021 Text][HB8900 2021 Comments] | 2022-09-19 Referred to the House Committee on Armed Services. |
| 2019-2020 116th Congress (Passed) | Provides continuing FY2021 appropriations to federal agencies through December 18, 2020, and extends several expiring health programs. DIVISION A--FURTHER CONTINUING APPROPRIATIONS ACT, 2021 Further Continuing Appropriations Act, 2021 This division p... [HB8900 2019 Detail][HB8900 2019 Text][HB8900 2019 Comments] | 2020-12-11 Became Public Law No: 116-215. (TXT | PDF) |
References Online
| Search Phrase | Web | News | Financial | Financial | Encylopedia | Biography | BioGuide |
|---|---|---|---|---|---|---|---|
| [US Congress HB8900] | Google Web | Google News | |||||
| [Representative Nita Lowey US] | Google Web | Google News | OpenSecrets | FollowTheMoney | Ballotpedia | VoteSmart | BioGuide |
Legislative Citation
APA
US HB8900 | 2019-2020 | 116th Congress. (2020, December 11). LegiScan. Retrieved April 25, 2024, from https://legiscan.com/US/bill/HB8900/2019
MLA
"US HB8900 | 2019-2020 | 116th Congress." LegiScan. LegiScan LLC, 11 Dec. 2020. Web. 25 Apr. 2024. <https://legiscan.com/US/bill/HB8900/2019>.
Chicago
"US HB8900 | 2019-2020 | 116th Congress." December 11, 2020 LegiScan. Accessed April 25, 2024. https://legiscan.com/US/bill/HB8900/2019.
Turabian
LegiScan. US HB8900 | 2019-2020 | 116th Congress. 11 December 2020. https://legiscan.com/US/bill/HB8900/2019 (accessed April 25, 2024).
Subjects
Administrative law and regulatory procedures
Aging
Appropriations
Child health
Department of Health and Human Services
Department of Justice
Digestive and metabolic diseases
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Economics and public finance
Education programs funding
Executive agency funding and structure
Food and Drug Administration (FDA)
Health care coverage and access
Health care quality
Health facilities and institutions
Health personnel
Health programs administration and funding
Health promotion and preventive care
Hospital care
Indian social and development programs
Marriage and family status
Medicaid
Medical education
Medicare
Mental health
Minority health
Prescription drugs
Sex and reproductive health
Aging
Appropriations
Child health
Department of Health and Human Services
Department of Justice
Digestive and metabolic diseases
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Economics and public finance
Education programs funding
Executive agency funding and structure
Food and Drug Administration (FDA)
Health care coverage and access
Health care quality
Health facilities and institutions
Health personnel
Health programs administration and funding
Health promotion and preventive care
Hospital care
Indian social and development programs
Marriage and family status
Medicaid
Medical education
Medicare
Mental health
Minority health
Prescription drugs
Sex and reproductive health
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| HB1375 | Related | 2020-12-09 | PAID Act Provide Accurate Information Directly Act | Received in the Senate and Read twice and referred to the Committee on Finance. |
| HB2281 | Related | 2020-11-18 | Easy MAT for Opioid Addiction Act Easy Medication Access and Treatment for Opioid Addiction Act | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| HB8337 | Related | 2020-10-01 | Continuing Appropriations Act, 2021 and Other Extensions Act | Became Public Law No: 116-159. (TXT | PDF) |
| SB1989 | Related | 2019-06-26 | PAID Act Provide Accurate Information Directly Act | Read twice and referred to the Committee on Finance. |
